Physician profile
Ryan Neilan
NPI 1134388382
$31,596.84
in general payments reported to CMS, 2019-2025
19 companies · $13K in 2025
The $13K reported for 2025 was more than what 97% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,600 · 2020: $964 · 2021: $3,401 · 2022: $4,608 · 2023: $781 · 2024: $4,338 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Food and Beverage: $4,496 · Travel and Lodging: $2,494.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,034.52 |
| Food and Beverage | $4,495.98 |
| Travel and Lodging | $2,494.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spirair, INC. | $13,611.54 | 2024-2025 | Septalign |
| Aerin Medical INC. | $7,174.43 | 2019-2025 | |
| Acclarent, INC | $5,029.57 | 2019-2023 | Trudi Nav Cable, Acclarent Aera, Relieva Spinplus |
| Intersect Ent, INC. | $2,680.30 | 2019-2021 | |
| Medical Device Business Services, INC. | $737.67 | 2019 | |
| Stryker Corporation | $450.91 | 2019-2022 | |
| Genzyme Corporation | $372.36 | 2023-2025 | |
| Optinose US, INC. | $356.68 | 2019-2024 | |
| Medtronic, INC. | $327.37 | 2022-2025 | Propel, Sinuva |
| Hologic Sales and Service, LLC | $165.13 | 2025 | Coolseal Generator |
| Inspire Medical Systems, INC. | $161.23 | 2023-2025 | Inspire |
| Baxter Healthcare | $112.46 | 2022 | |
| Glaxosmithkline, LLC. | $104.96 | 2022-2025 | Nucala |
| Neurent Medical Limited | $103.20 | 2025 | Neuromark System, Neuromark Radiofrequency Console |
| Olympus America INC. | $98.91 | 2019-2023 | Rhino-Laryngo Videoscope |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hikma Pharmaceuticals USA | $60.25 | 2024 | Ryaltris |
| Kaleo, INC. | $18.07 | 2024 | Auvi-Q |
| Merck Sharp & Dohme LLC | $17.57 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $14.23 | 2025 | Tezspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Neilan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.